A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

NCT01444430 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12460

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Symbicort pMDI
DRUG: budesonide pMDI

Sponsor

AstraZeneca